Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
Go back to Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.16 +0.04 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.12 | 52 Week High | $9.23 | |||
| Open | $10.28 | 52 Week Low | $1.16 | |||
| Day High | $10.73 | P/E | N/A | |||
| Day Low | $9.96 | EPS | $-0.30 | |||
| Volume | 3,034,792 | |||||
